Lets have a reality check here, there has to be a catalyst for ISIS to become $65.00 per share like another drug in the pipeline going from Phase III to being FDA approved and commercialized. I don't see that happening in three months. What I do see is that there will be news that will help to sustain the current price of ISIS shares. I predict that perhaps in the first quarter one of the drugs in Phase II advances into Phase III and in the second quarter of next year one or two of the drugs in the pipeline in Phase III gets submitted for FDA approval.
If all of the above happens then I see ISIS easily at $65 - $70 a share.